Skip to content

Evaluation of the effectiveness of VR teaching materials in retraining pharmacists after in situ simulation of emergency response-Multicenter randomized controlled trial.

Evaluation of the effectiveness of VR teaching materials in retraining pharmacists after in situ simulation of emergency response-Multicenter randomized controlled trial. - Evaluation of the effectiveness of VR teaching materials in retraining pharmacists after in situ simulation of emergency response.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000049252
Enrollment
140
Registered
2022-10-19
Start date
2022-10-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hospital pharmacists trained in in situ simulation of rapid response

Interventions

The VR group will be self-study with VR videos and resuscitation training kits
each study will last approximately 10 minutes and will be conducted once every three months. The control group will be taught face-to-face by a researcher who is a certified ACLS instructor
each learning session will last approximately 10 minutes and will be conducted once every three months.

Sponsors

Osaka University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Hospital pharmacists trained in in situ simulation of rapid response

Exclusion criteria

Exclusion criteria: Exclude participants who plan to retire within one year.

Design outcomes

Primary

MeasureTime frame
BLS self-efficacy scores one year after in situ simulation training

Secondary

MeasureTime frame
(1) Amount of change in BLS self-efficacy scores one year after in situ simulation training (2) Pass rate for BLS skills

Countries

Japan

Contacts

Public Contacttakuya shintani

Osaka University Hospital Department of Clinical Quality Management

shintani@hosp.med.osaka-u.ac.jp0668795111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026